Diagnostic Medical Systems S.A.
ALDMS.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.07 | -0.12 | -0.03 | 0.20 |
| FCF Yield | 0.22% | -21.95% | -10.04% | -35.41% |
| EV / EBITDA | -141.55 | 42.37 | -6.06 | -86.08 |
| Quality | ||||
| ROIC | -0.96% | -6.30% | -24.11% | -2.52% |
| Gross Margin | 39.92% | 36.30% | 39.22% | 38.28% |
| Cash Conversion Ratio | -1.28 | 0.33 | -0.11 | 0.23 |
| Growth | ||||
| Revenue 3-Year CAGR | 9.31% | 6.75% | 3.09% | 5.36% |
| Free Cash Flow Growth | 100.69% | -167.22% | 76.52% | -2.84% |
| Safety | ||||
| Net Debt / EBITDA | -73.67 | 18.42 | -2.25 | -32.05 |
| Interest Coverage | -0.15 | -4.97 | -26.11 | -2.18 |
| Efficiency | ||||
| Inventory Turnover | 1.92 | 1.75 | 1.64 | 1.94 |
| Cash Conversion Cycle | 117.31 | 144.88 | 136.86 | 147.40 |